MANE · Veradermics, Inc
$101.40
+2.89 (+2.93%)
At close · Sep 8
Going-concern doubt
— cleared Aug 11, 2026
The latest filing states the doubt was alleviated.
“In accordance with Accounting Standards Update ("ASU") 2014-15, Disclosure of Uncertainties about an Entity's Ability to Continue as a Going Concern (Subtopic 205-40), the Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued. ... As of June 30, 2026, we had $819.9 million in cash, cash equivalents and marketable securities. We expect our existing cash, cash equivalents and marketable securities will enable the Company to meet its obligations for at least the twelve-month period from the date the financial statements are available to be issued.”View the 10-Q filed Aug 11, 2026
Market Cap
$4.12B
Shares
41.78M
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Key facts
CIK
1827635
CUSIP
922967104
13F (30d)
118 filings
118 filers
Visit website
Investor relations